Home Antitrust Chronicle 2020 Spring 2020, Volume 2, Number 1

Spring 2020, Volume 2, Number 1

Antitrust Chronicle – May I – Healthcare


In this Chronicle we turn to the timely issue of healthcare and competition.

In light of the COVID-19 pandemic, the healthcare industry, in all its facets, including the development of pharmaceuticals, the provision of healthcare, and health insurance, has never been as vital. Antitrust rules have a key role to play to ensure that drug companies continue to innovate, vital care is provided to the public, and, above all, that patients receive the care they need.

In this Issue

In Case You Missed It

April 2020 - II

April 2020 - I

March 2020 - II

Chronicles by Year

Most Read Articles